Skip to content
buyWeak

Francisco Silva bought $10k of BRTX

VP of Research and Development at BioRestorative Therapies, Inc.. 8,308 shares at an average of $1.23, traded Apr 8, 2024, filed Apr 10, 2024.

Conviction score
36
Value
$10k
8,308 shares
Holdings after
155,759
+6% from before
From 52-week low
0%
low $1.28, close $1.28
From 52-week high
-80%
high $6.49, as of Apr 8, 2024

Score components

  • Role
    Officer
    +15
  • Trade size
    $10k at market
    0
  • Relative to holdings
    Holdings up 6%
    +3
  • Price context
    0% above the 52-week low; 80% below the 52-week high
    +18
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +5.4%, 3m +37.7%, 6m +25.9%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BRTXOct 13, 2026 · close 1.59
Since filing Apr 10, 2024: +22.3%SPY +55.8% · excess -33.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001021771-24-000091, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 8, 2024POpen-market purchase
Common Stock
+476$1.13$538147,927Apr 10, 2024
Apr 8, 2024POpen-market purchase
Common Stock
+1,232$1.17$1,441149,159Apr 10, 2024
Apr 9, 2024POpen-market purchase
Common Stock
+6,600$1.25$8,250155,759Apr 10, 2024

Related signals

Other insiders at BioRestorative Therapies, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
12Weak
BRTXsell
BioRestorative Therapies, Inc.
Dale Broadrick
owner
$1,757
1,112 shares
-0%
52Moderate
BRTXbuy
BioRestorative Therapies, Inc.
Dale Broadrick
owner
$206k
160,000 shares
+50%
42Moderate
BRTXbuy
BioRestorative Therapies, Inc.
Dale Broadrick
owner
$162k
120,000 shares
+37%
12Weak
BRTXsell
BioRestorative Therapies, Inc.
Dale Broadrick
owner
$469
250 shares
-0%
12Weak
BRTXsell
BioRestorative Therapies, Inc.
Dale Broadrick
owner
$525
278 shares
-0%
33Weak
BRTXbuy
BioRestorative Therapies, Inc.
Lance Alstodt
President, CEO, COB
$1,241
400 shares
+0%
33Weak
BRTXbuy
BioRestorative Therapies, Inc.
Lance Alstodt
President, CEO, COB
$602
200 shares
+0%
33Weak
BRTXbuy
BioRestorative Therapies, Inc.
Lance Alstodt
President, CEO, COB
$627
200 shares
+0%
33Weak
BRTXbuy
BioRestorative Therapies, Inc.
Lance Alstodt
President, CEO, COB
$1,244
400 shares
+0%
33Weak
BRTXbuy
BioRestorative Therapies, Inc.
Lance Alstodt
President, CEO, COB
$308
100 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Francisco Silva bought $10k of BRTX | InsiderTell